2021
DOI: 10.1111/febs.15738
|View full text |Cite
|
Sign up to set email alerts
|

GPCR signaling: role in mediating the effects of early adversity in psychiatric disorders

Abstract: Early adversity is a key risk factor for the development of several psychiatric disorders, including anxiety and depression. During early life, neurocircuits that regulate emotionality undergo substantial structural remodeling and functional maturation, and are thus particularly susceptible to modification by environmental experience. Preclinical evidence indicates that early stress enhances adult anxio-depressive behaviors. A commonality noted across diverse early stress models is life-long alterations in neu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
21
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 15 publications
(21 citation statements)
references
References 180 publications
(346 reference statements)
0
21
0
Order By: Relevance
“…Converging evidence across diverse models of early stress has implicated perturbations in GPCR signaling during these critical periods in the establishment and eventual emergence of disrupted anxio-depressive behaviors (Benekareddy et al, 2011; Pati et al, 2020; Sarkar et al, 2014; Soiza-Reilly et al, 2018; Teissier et al, 2019; Vinkers et al, 2010a). This has led to a hypothesis that a balance between Gq and Gi-mediated GPCR signaling within neocortical brain regions during these early developmental windows may be important to shaping the development of trait anxiety and behavioral despair (Lambe et al, 2011; Tiwari et al, 2021). A recent study has shown that enhanced Gq-signaling via chemogenetic hM3Dq-DREADD mediated activation of CamKIIα-positive forebrain excitatory neurons during the postnatal, but not the juvenile or adult, temporal windows results in long-lasting increases in anxiety and despair-like behavior, accompanied by perturbed sensorimotor gating and pre-pulse inhibition (PPI) deficits (Pati et al, 2020).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Converging evidence across diverse models of early stress has implicated perturbations in GPCR signaling during these critical periods in the establishment and eventual emergence of disrupted anxio-depressive behaviors (Benekareddy et al, 2011; Pati et al, 2020; Sarkar et al, 2014; Soiza-Reilly et al, 2018; Teissier et al, 2019; Vinkers et al, 2010a). This has led to a hypothesis that a balance between Gq and Gi-mediated GPCR signaling within neocortical brain regions during these early developmental windows may be important to shaping the development of trait anxiety and behavioral despair (Lambe et al, 2011; Tiwari et al, 2021). A recent study has shown that enhanced Gq-signaling via chemogenetic hM3Dq-DREADD mediated activation of CamKIIα-positive forebrain excitatory neurons during the postnatal, but not the juvenile or adult, temporal windows results in long-lasting increases in anxiety and despair-like behavior, accompanied by perturbed sensorimotor gating and pre-pulse inhibition (PPI) deficits (Pati et al, 2020).…”
Section: Discussionmentioning
confidence: 99%
“…It has been hypothesized that early stress may shift the balance towards enhanced excitatory Gq-coupled signaling accompanied by a decline in inhibitory Gi-coupled signaling in forebrain neurocircuits, which could contribute to the programing of perturbed anxiety and despair-like behaviors (Lambe et al, 2011; Sumner et al, 2008; Tiwari et al, 2021). Chemogenetic studies indicate that enhanced Gq-signaling in forebrain excitatory neurons during postnatal life programs long-lasting increases in anxiety and despair-like behavior along with disrupted sensorimotor gating (Pati et al, 2020).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Indeed almost all neurotransmitters involved in psychiatric disorders act directly through GPCRs [ 19 , 20 ]. Examples include but are not limited to serotonin and noradrenaline (depression and bipolar disorder) and dopamine (schizophrenia) (for review, see [ 21 , 22 , 23 , 24 , 25 ]). Lastly, GPCRs are the most common targets for drugs currently used to treat psychiatric disorders, and most neuropharmacological drugs are known to regulate GPCR activity in the CNS [ 21 , 22 ].…”
Section: Introductionmentioning
confidence: 99%